Mahasweta Chatterjee1, Sharmistha Saha1, Swagata Sinha1, Kanchan Mukhopadhyay2. 1. Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, 482 Madudah, Plot I-24, Sector J, EM Bypass, Kolkata, West Bengal, 700107, India. 2. Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, 482 Madudah, Plot I-24, Sector J, EM Bypass, Kolkata, West Bengal, 700107, India. drkanchanm@gmail.com.
Abstract
BACKGROUND: The serotonin transporter (SERT), encoded by the solute carrier family 6 number 4 (SLC6A4) gene, controls serotonin (5-HT) availability and is essential for the regulation of behavioral traits. Two SLC6A4 genetic variants, 5-HTTLPR and STin2, were widely investigated in patients with various neurobehavioral disorders, including attention deficit hyperactivity disorder (ADHD). METHODS: We analyzed the association of the 5-HTTLPR (L/S) and STin2 (10/12) variants, plasma 5-HT, and 5-hydroxyindole acetic acid (5-HIAA), as well as SERT messenger RNA (mRNA) with ADHD in the eastern Indian subjects. Nuclear families with ADHD probands (n = 274) and ethnically matched controls (n = 367) were recruited following the Diagnostic and Statistical Manual of Mental Disorders. Behavioral traits, executive function, and intelligence quotient (IQ) of the probands were assessed using the Conner's Parent Rating Scale - Revised, Parental Account of Children's Symptoms (PACS), Barkley Deficit in Executive Functioning-Child and Adolescent Scale, and Wechsler Intelligence Scale for Children-III, respectively. After obtaining informed written consent, peripheral blood was collected to analyze genetic variants, plasma 5-HT, 5-HIAA, and SERT mRNA expression. RESULTS: ADHD probands showed a higher frequency of the 5-HTTLPR "L" allele and "L/L" genotype (P < 0.05), lower 5-HIAA level, and higher SERT mRNA expression. Scores for behavioral problems and hyperactivity were higher in the presence of the "S" allele and "S/S" genotype, while executive deficit was higher in the presence of the "L" allele. IQ score was lower in the presence of the STin2 "12" allele and L-12 haplotype. CONCLUSION: Data obtained indicate a significant association of the serotoninergic system with ADHD, warranting further in-depth investigation.
BACKGROUND: The serotonin transporter (SERT), encoded by the solute carrier family 6 number 4 (SLC6A4) gene, controls serotonin (5-HT) availability and is essential for the regulation of behavioral traits. Two SLC6A4 genetic variants, 5-HTTLPR and STin2, were widely investigated in patients with various neurobehavioral disorders, including attention deficit hyperactivity disorder (ADHD). METHODS: We analyzed the association of the 5-HTTLPR (L/S) and STin2 (10/12) variants, plasma 5-HT, and 5-hydroxyindole acetic acid (5-HIAA), as well as SERT messenger RNA (mRNA) with ADHD in the eastern Indian subjects. Nuclear families with ADHD probands (n = 274) and ethnically matched controls (n = 367) were recruited following the Diagnostic and Statistical Manual of Mental Disorders. Behavioral traits, executive function, and intelligence quotient (IQ) of the probands were assessed using the Conner's Parent Rating Scale - Revised, Parental Account of Children's Symptoms (PACS), Barkley Deficit in Executive Functioning-Child and Adolescent Scale, and Wechsler Intelligence Scale for Children-III, respectively. After obtaining informed written consent, peripheral blood was collected to analyze genetic variants, plasma 5-HT, 5-HIAA, and SERT mRNA expression. RESULTS: ADHD probands showed a higher frequency of the 5-HTTLPR "L" allele and "L/L" genotype (P < 0.05), lower 5-HIAA level, and higher SERT mRNA expression. Scores for behavioral problems and hyperactivity were higher in the presence of the "S" allele and "S/S" genotype, while executive deficit was higher in the presence of the "L" allele. IQ score was lower in the presence of the STin2 "12" allele and L-12 haplotype. CONCLUSION: Data obtained indicate a significant association of the serotoninergic system with ADHD, warranting further in-depth investigation.
Authors: Jun Li; Yufeng Wang; Rulun Zhou; Haobo Zhang; Li Yang; Bing Wang; Stephen V Faraone Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-01-05 Impact factor: 3.568
Authors: E T Landaas; S Johansson; K K Jacobsen; M Ribasés; R Bosch; C Sánchez-Mora; C P Jacob; A Boreatti-Hümmer; S Kreiker; K-P Lesch; L A Kiemeney; J J S Kooij; C Kan; J K Buitelaar; S V Faraone; A Halmøy; J A Ramos-Quiroga; B Cormand; A Reif; B Franke; E Mick; P M Knappskog; J Haavik Journal: Genes Brain Behav Date: 2010-01-25 Impact factor: 3.449
Authors: Sabrina I Hanswijk; Daan van Rooij; Jaap Oosterlaan; Marjolein Luman; Pieter J Hoekstra; Catharina A Hartman; Barbara Franke; Emma Sprooten; Judith R Homberg; Jan K Buitelaar Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2021-05-15 Impact factor: 5.067
Authors: Robert D Oades; Jessica Lasky-Su; Hanna Christiansen; Stephen V Faraone; Edmund Js Sonuga-Barke; Tobias Banaschewski; Wai Chen; Richard Jl Anney; Jan K Buitelaar; Richard P Ebstein; Barbara Franke; Michael Gill; Ana Miranda; Herbert Roeyers; Aribert Rothenberger; Joseph A Sergeant; Hans-Christoph Steinhausen; Eric A Taylor; Margaret Thompson; Philip Asherson Journal: Behav Brain Funct Date: 2008-10-20 Impact factor: 3.759
Authors: Santosh K Yadav; Ajaz A Bhat; Sheema Hashem; Sabah Nisar; Madeeha Kamal; Najeeb Syed; Mohamed-Ramzi Temanni; Rakesh K Gupta; Saddat Kamran; Muhammad Waqar Azeem; Amit K Srivastava; Puneet Bagga; Sanjeev Chawla; Ravinder Reddy; Michael P Frenneaux; Khalid Fakhro; Mohammad Haris Journal: Transl Psychiatry Date: 2021-06-05 Impact factor: 6.222